Home › Plexiform Neurofibroma › Alabama › Birmingham
Plexiform Neurofibroma clinical trials in Birmingham, AL
4 studies for Plexiform Neurofibroma are looking for participants at sites in and around Birmingham (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas
RecruitingPhase 1
- Childrens of Alabama, Birmingham
A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1
RecruitingPhase 2
- University of Alabama at Birmingham, Birmingham
Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1
RecruitingPhase 2
- Childrens of Alabama, Birmingham
PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas
RecruitingPhase 1
- University of Alabama at Birmingham, Birmingham
Plexiform Neurofibroma trials in other cities
- Washington, DC7 studies
- Philadelphia, PA4 studies
- Indianapolis, IN3 studies
- Dallas, TX3 studies
- Los Angeles, CA3 studies
- Cincinnati, OH3 studies
Other studies in Birmingham
- Cancer (all types)30 studies
- Breast Cancer24 studies
- Obesity23 studies
- Ovarian Cancer23 studies
- Non-Small Cell Lung Cancer22 studies
- Acute Myeloid Leukemia21 studies
- Multiple Myeloma18 studies
- COPD17 studies
- Cardiovascular Disease17 studies
- Overweight16 studies
- Endometrial Cancer16 studies
- Type 2 Diabetes16 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.